Cholinergic nasal hyperreactivity in atopic subjects
- PMID: 4031317
- DOI: 10.1016/0091-6749(85)90725-0
Cholinergic nasal hyperreactivity in atopic subjects
Abstract
Increased nasal secretions are a fundamental component of allergic rhinitis. In order to analyze various parameters of nasal secretions, a relatively nontraumatic method for collecting nasal secretions was required. A small, flexible rubber catheter connected to a vacuum and inserted 4 cm into the nose proved to be an efficient method for recovering secretions produced from a series of nasal washes. An average of 67% of the washings were recovered and analyzed for protein content. Topical methacholine (5 to 100 mg) stimulated a dose-related increase in the amount of protein secreted with atopic patients demonstrating significantly more responsiveness than nonatopic patients (29.9 times the prechallenge production of protein for atopic patients and 4.8 times for nonatopic patients). Pretreatment with atropine (10 micrograms) reduced the effects of methacholine in atopic subjects, indicating that the secretory activity was in response to muscarinic receptor stimulation. Therefore, in addition to the array of autonomic abnormalities already recognized in atopic patients, these subjects are also hyperresponsive to nasal cholinergic stimulation.
Similar articles
-
Nasal cholinergic hyperresponsiveness in atopic subjects studied out of season.J Allergy Clin Immunol. 1993 Aug;92(2):278-87. doi: 10.1016/0091-6749(93)90171-b. J Allergy Clin Immunol. 1993. PMID: 8349938 Clinical Trial.
-
Pathophysiology of rhinitis. 1. Assessment of the sources of protein in methacholine-induced nasal secretions.Am Rev Respir Dis. 1988 Aug;138(2):413-20. doi: 10.1164/ajrccm/138.2.413. Am Rev Respir Dis. 1988. PMID: 3057965
-
The pathophysiology of rhinitis. III. The control of IgG secretion.J Allergy Clin Immunol. 1989 Dec;84(6 Pt 1):920-30. doi: 10.1016/0091-6749(89)90390-4. J Allergy Clin Immunol. 1989. PMID: 2480970
-
Duration of action of intranasal atropine on methacholine-induced nasal secretions.Arch Otolaryngol Head Neck Surg. 1996 Mar;122(3):321-3. doi: 10.1001/archotol.1996.01890150091016. Arch Otolaryngol Head Neck Surg. 1996. PMID: 8607961 Clinical Trial.
-
In vivo human models for the study of anticholinergic drugs.J Allergy Clin Immunol. 1995 May;95(5 Pt 2):1069-79. doi: 10.1016/s0091-6749(95)70210-5. J Allergy Clin Immunol. 1995. PMID: 7751524 Review.
Cited by
-
Nonallergic rhinitis. Pathophysiology and models for study.Eur Arch Otorhinolaryngol. 1995;252 Suppl 1:S27-32. doi: 10.1007/BF02484431. Eur Arch Otorhinolaryngol. 1995. PMID: 7734973 Review.
-
Kinin generation following methacholine nasal airway challenge of non-allergic subjects.Eur Arch Otorhinolaryngol. 1992;249(6):318-21. doi: 10.1007/BF00179380. Eur Arch Otorhinolaryngol. 1992. PMID: 1418940
-
Nasal provocation.Clin Rev Allergy. 1988 Fall;6(3):285-302. doi: 10.1007/BF02915037. Clin Rev Allergy. 1988. PMID: 3052775 Review. No abstract available.
-
Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen.J Clin Immunol. 1988 Mar;8(2):108-13. doi: 10.1007/BF00917898. J Clin Immunol. 1988. PMID: 2453530
-
Mechanisms of allergic rhinitis.Curr Allergy Asthma Rep. 2001 May;1(3):207-17. doi: 10.1007/s11882-001-0007-5. Curr Allergy Asthma Rep. 2001. PMID: 11892038 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources